IBM and Varian Medical Systems, Inc. (US) are leading players in Particle Therapy Market
The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. Growth in the particle therapy market can be attributed to factors such as the various advantages offered by particle therapy over photon therapy, increasing adoption of particle therapy in clinical trials, growing global prevalence of cancer, and the increasing number of particle therapy centers worldwide. On the other hand, issues related to the affordability and accessibility of treatments and the unfavorable reimbursement policies for particle therapy are the major factors that are expected to restrain the growth of this market in the coming years. The major players operating in the particle therapy market include Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), and Hitachi, Ltd. (Japan). Other players operating in this market include Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Lt...